iCo Therapeutics (“iCo” or the “Company”) (TSX-V: ICO) (OTCQB: ICOTF), iCo Therapeutics, Inc. (“iCo”) and…
eabramovichJanuary 6, 2021
Dr. Joseph Connors, Clinical Professor Emeritus in the Department of Medicine at UBC, was appointed…
eabramovichJanuary 4, 2021
The holiday season is upon us, and as research begins to slow towards the end…
eabramovichDecember 21, 2020
TRIUMF has announced a new research partnership with Ontario-based Fusion Pharmaceuticals to expand production and availability of actinium-225,…
eabramovichDecember 18, 2020
The host environment in which infection occurs plays a crucial role in the interaction between Pseudomonas…
eabramovichDecember 18, 2020
In its 20th year, the Canada Research Chairs Program continues to provide opportunities for researchers…
eabramovichDecember 18, 2020
When the COVID-19 pandemic hit British Columbia at the beginning of 2020, its effect on…
eabramovichDecember 17, 2020
